AxoGen, Inc. (0HKD.L)

USD 16.93

(0.5%)

Operating Expenses Summary of AxoGen, Inc.

  • AxoGen, Inc.'s latest annual operating expenses in 2023 was 149.33 Million USD , up 3.6% from previous year.
  • AxoGen, Inc.'s latest quarterly operating expenses in 2024 Q2 was 35.77 Million USD , down -3.78% from previous quarter.
  • AxoGen, Inc. reported a annual operating expenses of 144.14 Million USD in annual operating expenses 2022, up 11.01% from previous year.
  • AxoGen, Inc. reported a annual operating expenses of 129.84 Million USD in annual operating expenses 2021, up 14.0% from previous year.
  • AxoGen, Inc. reported a quarterly operating expenses of 35.77 Million USD for 2024 Q2, down -3.78% from previous quarter.
  • AxoGen, Inc. reported a quarterly operating expenses of 36.95 Million USD for 2023 Q4, down -0.79% from previous quarter.

Annual Operating Expenses Chart of AxoGen, Inc. (2023 - 1989)

Historical Annual Operating Expenses of AxoGen, Inc. (2023 - 1989)

Year Operating Expenses Operating Expenses Growth
2023 149.33 Million USD 3.6%
2022 144.14 Million USD 11.01%
2021 129.84 Million USD 14.0%
2020 113.9 Million USD -5.69%
2019 120.76 Million USD 31.97%
2018 91.51 Million USD 54.93%
2017 59.06 Million USD 38.1%
2016 42.77 Million USD 34.71%
2015 31.74 Million USD 36.99%
2014 23.17 Million USD 28.05%
2013 18.09 Million USD 33.76%
2012 13.53 Million USD 44.08%
2011 9.39 Million USD 384.16%
2010 1.93 Million USD -78.34%
2009 8.95 Million USD 692.88%
2008 1.12 Million USD 25.45%
2007 900.35 Thousand USD 71.81%
2006 524.03 Thousand USD -31.93%
2005 769.87 Thousand USD -35.28%
2004 1.18 Million USD -60.17%
2003 2.98 Million USD -27.71%
2002 4.13 Million USD -51.02%
2001 8.43 Million USD -5.44%
2000 8.91 Million USD 31.17%
1999 6.8 Million USD 38.78%
1998 4.9 Million USD -7.55%
1997 5.3 Million USD -20.9%
1996 6.7 Million USD 1.52%
1995 6.6 Million USD 73.68%
1994 3.8 Million USD 18.75%
1993 3.2 Million USD 33.33%
1992 2.4 Million USD 9.09%
1991 2.2 Million USD -8.33%
1990 2.4 Million USD 0.0%
1989 2.4 Million USD 9.09%

Peer Operating Expenses Comparison of AxoGen, Inc.

Name Operating Expenses Operating Expenses Difference
Phreesia, Inc. 369.84 Million USD 59.622%
Accuray Incorporated 142.61 Million USD -4.711%
Align Technology, Inc. 2.07 Billion USD 92.809%
Elevance Health Inc. 36.23 Billion USD 99.588%
Boston Scientific Corporation 7.5 Billion USD 98.01%
CVS Health Corporation 40.68 Billion USD 99.633%
Cardinal Health, Inc. 5 Billion USD 97.013%
Centene Corporation 138.33 Billion USD 99.892%
DaVita Inc. 1.47 Billion USD 89.869%
HCA Healthcare, Inc. 45.43 Billion USD 99.671%
Hologic, Inc. 1.26 Billion USD 88.219%
Humana Inc. 102.36 Billion USD 99.854%
IDEXX Laboratories, Inc. 1.09 Billion USD 86.335%
Laboratory Corporation of America Holdings 2.02 Billion USD 92.612%
Masimo Corporation 867 Million USD 82.776%
McKesson Corporation 8.67 Billion USD 98.279%
Patterson Companies, Inc. 1.12 Billion USD 86.753%
Quest Diagnostics Incorporated 1.61 Billion USD 90.724%
ResMed Inc. 1.36 Billion USD 89.087%
Henry Schein, Inc. 2.93 Billion USD 94.915%
Teladoc Health, Inc. 2.09 Billion USD 92.858%
Universal Health Services, Inc. 9.2 Billion USD 98.378%
Veeva Systems Inc. 1.25 Billion USD 88.12%
Baxter International Inc. 5.27 Billion USD 97.167%
Becton, Dickinson and Company 6.71 Billion USD 97.775%
Intuitive Surgical, Inc. 2.96 Billion USD 94.959%
Danaher Corporation 8.75 Billion USD 98.294%
Stryker Corporation 9.2 Billion USD 98.378%
Medtronic plc 16.12 Billion USD 99.074%